Cargando…

Treatment With Recombinant Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand Alleviates the Severity of Streptozotocin-Induced Diabetes

OBJECTIVE: To evaluate the potential therapeutic effect of recombinant human tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) treatment in a model of type 1 diabetes. RESEARCH DESIGN AND METHODS: Recombinant TRAIL was added in vitro to primary human and mouse peripheral blood mo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zauli, Giorgio, Toffoli, Barbara, di Iasio, Maria Grazia, Celeghini, Claudio, Fabris, Bruno, Secchiero, Paola
Formato:	Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2010
Materias:	Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2857907/ https://www.ncbi.nlm.nih.gov/pubmed/20185810 http://dx.doi.org/10.2337/db09-1771

Ejemplares similares

Association of Serum Tumor Necrosis Factor-Related Apoptosis Inducing Ligand with Body Fat Distribution as Assessed by Dual X-Rays Absorptiometry
por: Cervellati, Carlo, et al.
Publicado: (2014)

TNF-Related Apoptosis Inducing Ligand in Ocular Cancers and Ocular Diabetic Complications
por: Perri, Paolo, et al.
Publicado: (2015)

Levels of circulating TNF-related apoptosis-inducing ligand in celiac disease
por: CELEGHINI, CLAUDIO, et al.
Publicado: (2014)

Association of Soluble Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) with Central Adiposity and Low-Density Lipoprotein Cholesterol
por: Brombo, Gloria, et al.
Publicado: (2013)

TRAIL/DR5 pathway promotes AKT phosphorylation, skeletal muscle differentiation, and glucose uptake
por: Toffoli, Barbara, et al.
Publicado: (2021)

Endothelial Cells Obtained from Patients Affected by Chronic Venous Disease Exhibit a Pro-Inflammatory Phenotype
por: Tisato, Veronica, et al.
Publicado: (2012)

TRAIL Modulates the Immune System and Protects against the Development of Diabetes
por: Bossi, Fleur, et al.
Publicado: (2015)

Sodium dichloroacetate exhibits anti-leukemic activity in B-chronic lymphocytic leukemia (B-CLL) and synergizes with the p53 activator Nutlin-3
por: Agnoletto, Chiara, et al.
Publicado: (2014)

Palmitic Acid Induced a Long-Lasting Lipotoxic Insult in Human Retinal Pigment Epithelial Cells, which Is Partially Counteracted by TRAIL
por: Sergi, Domenico, et al.
Publicado: (2022)

Intranasal Administration of Recombinant TRAIL Down-Regulates CXCL-1/KC in an Ovalbumin-Induced Airway Inflammation Murine Model
por: Tisato, Veronica, et al.
Publicado: (2014)

Ibrutinib synergizes with MDM-2 inhibitors in promoting cytotoxicity in B chronic lymphocytic leukemia
por: Voltan, Rebecca, et al.
Publicado: (2016)

TRAIL, OPG, and TWEAK in kidney disease: biomarkers or therapeutic targets?
por: Bernardi, Stella, et al.
Publicado: (2019)

Soluble TRAIL does not impair the anti-osteoclastic activity of osteoprotegerin
por: Zauli, Giorgio, et al.
Publicado: (2008)

Rationale for Considering Oral Idasanutlin as a Therapeutic Option for COVID-19 Patients
por: Zauli, Giorgio, et al.
Publicado: (2020)

Overcoming of Microenvironment Protection on Primary Chronic Lymphocytic Leukemia Cells after Treatment with BTK and MDM2 Pharmacological Inhibitors
por: Rimondi, Erika, et al.
Publicado: (2021)

Wdr13 and streptozotocin-induced diabetes
por: Mishra, Arun Prakash, et al.
Publicado: (2018)

Sensitization of recombinant human tumor necrosis factor-related apoptosis-inducing ligand-resistant malignant melanomas by quercetin
por: Turner, Katherine A., et al.
Publicado: (2018)

Keratin-Dependent, Epithelial Resistance to Tumor Necrosis Factor-Induced Apoptosis
por: Caulin, Carlos, et al.
Publicado: (2000)

TRAIL and Ceruloplasmin Inverse Correlation as a Representative Crosstalk between Inflammation and Oxidative Stress
por: Tisato, Veronica, et al.
Publicado: (2018)

Lipids at the Nexus between Cerebrovascular Disease and Vascular Dementia: The Impact of HDL-Cholesterol and Ceramides
por: Sergi, Domenico, et al.
Publicado: (2023)

Tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) and receptors in type 1, type 2 and type 17 inflammation in cross-sectional asthma study
por: Marks, Michelle, et al.
Publicado: (2020)

Therapeutic effects of balanitoside in streptozotocin-induced diabetic rats
por: Makena, Wusa, et al.
Publicado: (2018)

Marine Drugs Regulating Apoptosis Induced by Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL)
por: Elmallah, Mohammed I. Y., et al.
Publicado: (2015)

Cell-Based Therapies for Diabetic Complications
por: Bernardi, Stella, et al.
Publicado: (2012)

Critical Contribution of Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand (Trail) to Apoptosis of Human Cd4(+)T Cells in HIV-1–Infected Hu-Pbl-Nod-Scid Mice
por: Miura, Yoshiharu, et al.
Publicado: (2001)

Clinical perspectives of TRAIL: insights into central nervous system disorders
por: Tisato, Veronica, et al.
Publicado: (2016)

MDM2/X inhibitors under clinical evaluation: perspectives for the management of hematological malignancies and pediatric cancer
por: Tisato, Veronica, et al.
Publicado: (2017)

Potential Prognostic Significance of Decreased Serum Levels of TRAIL after Acute Myocardial Infarction
por: Secchiero, Paola, et al.
Publicado: (2009)

Ergosterol Alleviates Kidney Injury in Streptozotocin-Induced Diabetic Mice
por: Ang, Li, et al.
Publicado: (2015)

Omarigliptin alleviates cognitive dysfunction in Streptozotocin-induced diabetic mouse
por: Li, Xiaoyan, et al.
Publicado: (2022)

Upregulation of SOCS-1 by Nutlin-3 in acute myeloid leukemia cells but not in primary normal cells
por: Tisato, Veronica, et al.
Publicado: (2014)

Synergistic Induction of Apoptosis in Primary B-CLL Cells after Treatment with Recombinant Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand and Histone Deacetylase Inhibitors
por: Norian, Lyse A., et al.
Publicado: (2009)

Tumor necrosis factor-related apoptosis-inducing ligand inhibits proliferation and induces apoptosis of prostate and bladder cancer cells
por: Hao, Lin, et al.
Publicado: (2017)

Berberine enhances tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in breast cancer
por: REFAAT, ALAA, et al.
Publicado: (2013)

Secretion of tumoricidal human tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) by recombinant Lactococcus lactis: optimization of in vitro synthesis conditions
por: Ciaćma, Katarzyna, et al.
Publicado: (2018)

Tumour necrosis factor-related apoptosis-inducing ligand expression in patients with diabetic nephropathy
por: Chang, Wei-wei, et al.
Publicado: (2018)

Therapeutic potential of the MDM2 inhibitor Nutlin-3 in counteracting SARS-CoV-2 infection of the eye through p53 activation
por: Zauli, Giorgio, et al.
Publicado: (2022)

Exenatide Reduces Tumor Necrosis Factor-α-induced Apoptosis in Cardiomyocytes by Alleviating Mitochondrial Dysfunction
por: Cao, Yuan-Yuan, et al.
Publicado: (2015)

Effect of Granulocyte Colony-Stimulating Factor on the Peripheral Nerves in Streptozotocin-Induced Diabetic Rat
por: Lee, Kyung Ae, et al.
Publicado: (2013)

Streptozotocin-Induced Hyperglycemia Is Associated with Unique Microbiome Metabolomic Signatures in Response to Ciprofloxacin Treatment
por: Wurster, Jenna I., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_lf61jkea2bhqn111ubliqe2c0p